Investment Summary

Ampersand Capital Partners and TPG Invest In Confluent Medical

On April 25, 2011, growth capital firm Ampersand Capital Partners and private equity firm TPG invested in medical products company Confluent Medical

Investment Highlights
  • This is Ampersand Capital Partners’ 8th and TPG’s 7th transaction in the Medical Products sector.
  • This is Ampersand Capital Partners’ 23rd and TPG’s 120th transaction in the United States.
  • This is Ampersand Capital Partners’ 2nd and TPG’s 4th transaction in Arizona.

Investment Summary

Date 2011-04-25
Target Confluent Medical
Sector Medical Products
Investor(s) Ampersand Capital Partners
TPG
Deal Type Growth Capital
Advisor(s) J.P. Morgan Securities (Financial)
Goodwin Procter (Legal)

Target

Confluent Medical

Scottsdale, Arizona, United States
website
Confluent Medical is a contract manufacturer of Nitinol-based and balloon catheter medical devices. Confluent provides a broad range of capabilities including developing and manufacturing components, delivery systems, and finished devices for medical device OEMs in many of the fastest-growing healthcare subsectors, including neurovascular, structural heart, electrophysiology, aortic intervention, peripheral vascular, and ENT. Confluent Medical was founded in 1991 and is based in Scottsdale, Arizona.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 23 of 79
Sector (Medical Products) 8 of 16
Type (Growth Capital) 4 of 26
State (Arizona) 2 of 3
Country (United States) 23 of 65
Year (2011) 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-04 Blue Sky BioServices

Worcester, Massachusetts, United States

Blue Sky BioServices is a contract research organization (CRO) that provides gene through screen services in the pharmaceutical and biotechnology R&D market. Blue Sky BioServices was founded in 2003 and is based in Worcester, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-14 CoreLab Partners

Princeton, New Jersey, United States

CoreLab Partners, Inc. is a provider of linical trials, medical image assessment, and cardiac safety solutions.

Buy -
Investor

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1992
PE ASSETS 137.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


DEAL STATS #
Overall 176 of 401
Sector (Medical Products) 7 of 14
Type (Growth Capital) 17 of 63
State (Arizona) 4 of 8
Country (United States) 120 of 269
Year (2011) 8 of 20
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-05 Resource Label Group

Franklin, Tennessee, United States

Resource Label Group is a full-service label company providing custom label design and printing for a wide range of industries. In addition to complete label printing capabilities, our label company offers specialty label customizations. Resource Label Group was established in 1996 and is based in Franklin, Tennessee.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-11 CardioDx

Redwood City, California, United States

CardioDx, Inc. is a molecular diagnostics company that serves cardiologists and their patients by offering clinically validated genomic tests to enhance patient care. The company is focused on the personalized management of patients with congestive heart failure, rhythm disturbances and atherosclerosis.

Buy -